NEW YORK (GenomeWeb News) – Illumina reported after the close of the market Monday that its first-quarter revenues increased 21 percent year over year as the firm swung to a loss due to litigation-related charges.

The San Diego-based firm posted revenues of $331 million for the three months ended March 31, compared to $272.8 million for the first quarter of 2012. It beat the average analyst estimate of $310.7 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: the Human Silencing Hub protein complex, and more.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.